Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Ruth Lopert"'
Publikováno v:
Globalization and Health, Vol 14, Iss 1, Pp 1-11 (2018)
Abstract Background The inclusion of patent linkage mechanisms in bilateral and plurilateral trade and investment agreements has emerged as a key element in the United States’ TRIPS-Plus intellectual property (IP) negotiating agenda. However, the p
Externí odkaz:
https://doaj.org/article/327746ee18d644b29e09dd5dcbe67b25
Autor:
Elizabeth Docteur, Ruth Lopert
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015)
Externí odkaz:
https://doaj.org/article/e765dcf9d55a4fb8b6991ae2a9942920
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015)
Externí odkaz:
https://doaj.org/article/ffbf7cc446874c1dba230b3754167c1e
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 40, Iss 1, Pp 5-6 (2016)
Externí odkaz:
https://doaj.org/article/2aef510b0ae844ddb26a5dbf515df3f0
Publikováno v:
Population Medicine. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9347e6518a31f813fa3b54df521417ef
https://doi.org/10.18332/popmed/165389
https://doi.org/10.18332/popmed/165389
Autor:
Denis Horgan, Tanja Spanic, Kathi Apostolidis, Giuseppe Curigliano, Joanna Chorostowska-Wynimko, Hans-Peter Dauben, Jonathan A. Lal, Rafal Dziadziuszko, Christine Mayer-Nicolai, Marta Kozaric, Bengt Jönsson, Iñaki Gutierrez-Ibarluzea, Marie-Helene Fandel, Ruth Lopert
Publikováno v:
Healthcare (Basel, Switzerland). 10(8)
Significant progress has been achieved in human health in the European Union in recent years. New medicines, vaccines, and treatments have been developed to tackle some of the leading causes of disease and life-threatening illnesses. It is clear that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d54b653ae7604c95c98c35d7826432
https://pubmed.ncbi.nlm.nih.gov/36011250
https://pubmed.ncbi.nlm.nih.gov/36011250
Autor:
Ameet Sarpatwari, Marie L. De Bruin, Joel Lexchin, Ruth Lopert, Barbara Mintzes, Alice Bhasale, Priya Bahri
Publikováno v:
Clinical Pharmacology and Therapeutics, 109(6), 1424. Nature Publishing Group
In the wake of the withdrawal of the nonsteroidal anti-inflammatory drug rofecoxib, regulators worldwide reconsidered their approach to postmarket safety. Many have since adopted a “life cycle” approach to regulation of medicines, facilitating fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c251b129675f9dccb2b736169628e5
https://doi.org/10.1002/cpt.2010
https://doi.org/10.1002/cpt.2010
Autor:
Ruth Lopert
Publikováno v:
BMJ. :p248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ee9ce72c24634b4a1fd4f341e49827
https://doi.org/10.1136/bmj.p248
https://doi.org/10.1136/bmj.p248
Publikováno v:
OECD Health Working Papers.
With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide – and sustain – access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f57228f145a7a1cdc082efe55859aafe
https://doi.org/10.1787/4b2e9cb9-en
https://doi.org/10.1787/4b2e9cb9-en
Publikováno v:
The Journal of World Intellectual Property. 21:88-103
This paper explores Japan's role in reshaping the global pharmaceutical intellectual property regime by examining its position on the expansion of intellectual property rights (IPR) in negotiations for two regional trade agreements: the Trans Pacific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee3ccdc2890dedb2a723adb67c5a396
https://doi.org/10.1111/jwip.12099
https://doi.org/10.1111/jwip.12099